Sexual function and disease progression in women with advanced cancer
- PMID: 35224655
- DOI: 10.1007/s00520-022-06797-x
Sexual function and disease progression in women with advanced cancer
Abstract
Purpose: To prospectively evaluate sexual function, body image, quality of life, and disease progression rates in women with advanced cancer.
Methods: Sixty women staged III-IV breast, gynaecological, or colorectal cancer completed the Female Sexual Function Index (FSFI), the Body Image Scale, the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTQL), and the Beck Depression Inventory. Forty-three women (71.67%) completed the questionnaires again approximately 1 year later. The Wilcoxon test was used to compare the scores between the two evaluations. The participants were informed that they could attend additional consultations for symptom control or management of sexual difficulties if they wished.
Results: Twenty-eight women showed disease progression (65.12%), and seven died. Twenty-one women remained sexually active (48.8%), all of whom were married/partnered. There was no difference in the FSFI score over time [28 (21.4-32.1) vs. 30.3 (24.2-33.3) P = 0.19]. The body image scores improved [6 (1-15) vs. 3 (0-10), P = 0.039], while the perceived global health status worsened [EORTQL: 75 (50-83.3) vs. 41.7 (25-50), P = 0.001].
Conclusions: Body image scores improved over time despite a concomitant decrease in the perceived global health status. A portion of women with recurrent or metastatic cancer remained interested in sexual intimacy. New studies are needed to understand the differences between the needs of women with advanced cancer who are vs. are not sexually active, for the development of more effective therapeutic approaches.
Keywords: Advanced cancer; Body image; Cancer; Female sexuality; Quality of life; Sexual function.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Hordern AJ, Street AF (2007) Let’s talk about sex: risky business for cancer and palliative care clinicians. Contemp Nurse 27(1):49–60. https://doi.org/10.5555/conu.2007.27.1.49 - DOI - PubMed
-
- Jackson SE, Wardle J, Steptoe A, Fisher A (2016) Sexuality after a cancer diagnosis: a population-based study. Cancer 122:3883–3891. https://doi.org/10.1002/cncr.30263 - DOI - PubMed
-
- McClelland SI, Holland K, Griggs JJ (2015) Vaginal dryness and beyond: the sexual health needs of women diagnosed with metastatic breast cancer. J Sex Res 2(6):604–616. https://doi.org/10.1080/00224499.2014.928663 - DOI
-
- Rouanne M, Massard C, Hollebecque A, Rousseau V, Varga A, Gazzah A, Neuzillet Y, Lebret T, Soria JC (2013) Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a Phase I clinical trial unit of predominantly targeted anticancer drugs. Eur J Cancer 9(2):431–438. https://doi.org/10.1016/j.ejca.2012.08.008 - DOI
-
- Lindau ST, Gavrilova N, Anderson ND (2007) Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms. Gynecol Oncol 106(2):413–418. https://doi.org/10.1016/j.ygyno.2007.05.017 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
